Passage Bio
Stock Forecast, Prediction & Price Target
Passage Bio Financial Estimates
Passage Bio Revenue Estimates
Passage Bio EBITDA Estimates
Passage Bio Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $1.9M Low: $1.9M High: $1.9M avg. 0% | Avg: $400K Low: $400K High: $400K avg. -78.94% | Avg: $46.96M Low: $46.96M High: $46.96M avg. 11640.5% | Avg: $162.75M Low: $162.75M High: $162.75M avg. 246.57% |
Net Income
% change YoY
| $-191.5M N/A | $-136.85M 28.53% | $-102.06M 25.42% | Avg: $-85.65M Low: $-84.30M High: $-27.91M avg. 16.07% | Avg: $-89.37M Low: $-78.83M High: $-26.82M avg. -4.34% | Avg: $-19.34M Low: $-19.34M High: $-19.34M avg. 78.35% | Avg: $28.64M Low: $28.64M High: $28.64M avg. 248.11% |
EBITDA
% change YoY
| $-169.72M N/A | $-132.39M 21.99% | $-98.34M 25.72% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$3.59 N/A | -$2.51 30.08% | -$1.86 25.89% | Avg: -$0.86 Low: -$1.54 High: -$0.51 avg. 54.03% | Avg: -$0.88 Low: -$1.44 High: -$0.49 avg. -2.53% | Avg: -$0.35 Low: -$0.35 High: -$0.35 avg. 59.69% | Avg: $0.52 Low: $0.52 High: $0.52 avg. 248.11% |
Operating Expenses
% change YoY
| $177.72M N/A | $135.39M -23.81% | $108.38M -19.94% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Passage Bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 84.55% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -84.30M, average is -85.65M and high is -27.91M.
What is Passage Bio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 2952.03% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $1.9M, average is $1.9M and high is $1.9M.
What is Passage Bio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 89.82% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.54, average is -$0.86 and high is $-0.51.
What is the best performing analyst?
In the last twelve months analysts have been covering Passage Bio stock. The most successful analyst is Danielle Brill.